In people with Type 1 diabetes (T1D), the immune system shuts down the body's ability to make the hormone insulin, ...

Researchers combined electronic sensors with human islet cells to create living ‘cyborg’ organoids transmitting troves of ...

The U.S. Food ⁠and ⁠Drug Administration has authorized ⁠the granting of early access before ​regulatory approval to ...

Diabetes mellitus affects more than 500 million people worldwide, and both Type 1 (T1D) and Type 2 (T2D) forms converge on a common endpoint: the loss or ...

A family battling Stage 4 pancreatic cancer is raising funds for research, and hopefully a cure, one cup of lemonade at a ...

Pancreatic cancer remains one of the most difficult cancers to treat, in large part because tumors do not exist in isolation.

Former Sen. Ben Sasse of Nebraska reveals an experimental cancer drug helped shrink his tumors by 76% after a stage 4 ...

Nuclear medicine is being called a new frontier in cancer care, and new research shows potential new uses for it in treating ...

Follow along as the PanCAN community speaks up, stands together and contacts Congress to prioritize patients and researchers ...

These malignant growths involve the neuroendocrine cells, which can both send out nerve signals and secrete hormones.